Adverse Events
31
5
5
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.2%
1 terminated out of 31 trials
92.9%
+6.4% vs benchmark
3%
1 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (31)
Prospective Assessment Project of AirwaY Management-related Incidents in Adult Anaesthesia Care PAPAYA III
Impact of SCFA Supplementation on Gut Microbiome Composition of Kidney Transplant Recipients
Impact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.
CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
Amino Acid Infusion in Kidney Transplant Recipients
ABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery
Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy
Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma
The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization
Studying the Senescent T Cell Features and Its Relationship with the Chemotherapy Efficacy in Young TNBC
Post-marketing Safety and Efficacy Surveillance of Motherwort Injection
Incidence of Adverse Airway Events in High Risk Patients Undergoing Upper GI Endoscopy Under Anesthesia
Retrospective Independent Safety Review of Closed Irrisept Study
Plasmapheresis: a Multi-modal Approach
Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS
Lifeflight: Fentanyl Versus Morphine
Effectiveness of a Proficiency-based Progression Communication Training Programme
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Niraparib Plus Anlotinib for Recurrent Ovarian Cancer
Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer